They develop quietly—often long before symptoms are obvious.
IHeartSense DX brings AI-governed cardiac ultrasound into the home, allowing adults and parents to gain early reassurance or timely escalation without waiting weeks for hospital scans.
This is not an ECG.
This is not a wearable.
This is structural heart assessment, guided and controlled by AI.
What IHeartSense DX Does
IHeartSense DX uses a wireless handheld ultrasound device and advanced AI to perform a focused cardiac assessment safely outside clinical settings.
You don’t operate the scan.
You don’t adjust settings.
You don’t interpret images.
The AI does everything.
It controls:
probe positioning
ultrasound power
capture timing
safety limits
When enough information has been captured, the system delivers clear, interpreted results, not confusing images.
Clear Results, Not Guesswork
Instead of raw scans, IHeartSense DX provides simple, understandable outcomes such as:
Fine
No enlargement detected
No major abnormality detected
Escalation recommended
This allows you to act early, seek reassurance, or escalate appropriately—without panic or delay.
Why This Matters
Millions of people experience chest symptoms, palpitations, or anxiety and are sent home without imaging
Parents are often left waiting weeks for infant cardiac reassurance
Hospitals reserve echocardiograms for advanced cases, not early concerns
IHeartSense DX fills the gap.
It sits between:
basic monitoring devices
and
full hospital echocardiography
bringing controlled, AI-managed ultrasound assessment into everyday life.
Designed for Safety and Simplicity
No manual imaging controls
No user interpretation
No complex operation
AI-enforced safety at every step
The system is designed to support early awareness and reassurance, not replace clinicians.
A New Category of Home Health
IHeartSense DX introduces a new class of home technology:
AI-governed cardiac ultrasound.
For adults.
For parents.
For peace of mind when waiting is not an option.
Pre-order now. Estimated release mid-September 2026, subject to regulatory clearance.